Epimerase activity of the human 11β-hydroxysteroid dehydrogenase type 1 on 7-hydroxylated C19-steroids

Journal of Steroid Biochemistry and Molecular Biology

Volumn 114, Issue 1-2, 2009, Pages 57-63

  Hennebert, Olivier ^a   Montes, Matthieu ^b   Favre Reguillon, Alain ^b   Chermette, Henry ^c   Ferroud, Clotilde ^b   Morfin, Robert ^a  

^a EA 3199   (France)

^b Bioinformatique et Chimie Moléculaire   (France)

^c CNRS   (France)

Author keywords

11 HSD1; Cortisol; Cortisone; DHEA; Epiandrosterone; NADPH; Oxidoreduction

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 3BETA ANDROSTANEDIOL; 7 OXO 5ALPHA ANDROSTANE 3BETA,17BETA DIOL; 7 OXO DEHYDROEPIANDROSTERONE; 7ALPHA 5ALPHA ANDROSTANE 3BETA,17BETA DIOL; 7ALPHA HYDROXY DEHYDROEPIANDROSTERONE; 7ALPHA HYDROXY EPIANDOSTERONE; 7BETA 5ALPHA ANDROSTANE 3BETA,17BETA DIOL; 7BETA HYDROXY DEHYDROEPIANDROSTERONE; 7BETA HYDROXY EPIANDOSTERONE; CORTISONE; EPIANDROSTERONE; EPIMERASE; HYDROCORTISONE; STEROID; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVITY; EPIMERIZATION; OXIDATION REDUCTION REACTION; STEROID METABOLISM; STEROID RELEASE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANDROSTANE-3,17-DIOL; ANDROSTERONE; CATALYTIC DOMAIN; DEHYDROEPIANDROSTERONE; HUMANS; HYDROXYLATION; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; STEROID HYDROXYLASES; STEROIDS;

EID: 63249104729     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.12.015     Document Type: Article

References (30)

1. Labrie F., Luuthe V., Labrie C., and Simard J. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front. Neuroendocrinol. 22 (2001) 185-212
2. Schwarz M., Lund E.G., Lathe R., Bjorkhem I., and Russell D.W. Identification and characterization of a mouse oxysterol 7 alpha- hydroxylase cDNA. J. Biol. Chem. 272 (1997) 23995-24001
3. Rose K.A., Stapleton G., Dott K., Kieny M.P., Best R., Schwarz M., Russell D.W., Bjorkhem I., Seckl J., and Lathe R. Cyp7b, a novel brain cytochrome p450, catalyzes the synthesis of neurosteroids 7alpha-hydroxy dehydroepiandrosterone and 7alpha-hydroxy pregnenolone. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4925-4930
4. Kim S.B., Chalbot S., Pompon D., Jo D.H., and Morfin R. The human cytochrome P4507B1: catalytic activity studies. J. Steroid Biochem. Mol. Biol. 92 (2004) 383-389
5. Chalbot S., and Morfin R. Human liver S9 fractions: metabolism of dehydroepiandrosterone, epiandrosterone, and related 7-hydroxylated derivatives. Drug Metab. Dispos. 33 (2005) 563-569
6. Chalbot S., and Morfin R. Neurosteroids: metabolism in human intestine microsomes. Steroids 70 (2005) 319-326
7. Hennebert O., Chalbot S., Alran S., and Morfin R. Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. J. Steroid Biochem. Mol. Biol. 104 (2007) 326-333
8. Trap C., Nato F., Chalbot S., Kim S.B., Lafaye P., and Morfin R. Immunohistochemical detection of the human cytochrome P4507B1: production of a monoclonal antibody after cDNA immunization. J. Neuroimmunol. 159 (2005) 41-47
9. Muller C., Pompon D., Urban P., and Morfin R. Inter-conversion of 7alpha- and 7beta-hydroxy-dehydroepiandrosterone by the human 11beta-hydroxysteroid dehydrogenase type 1. J. Steroid Biochem. Mol. Biol. 99 (2006) 215-222
10. Hennebert O., Pernelle C., Ferroud C., and Morfin R. 7Alpha- and 7beta-hydroxy-epiandrosterone as substrates and inhibitors for the human 11beta-hydroxysteroid dehydrogenase type 1. J. Steroid Biochem. Mol. Biol. 105 (2007) 159-165
11. Hennebert O., Le Mee S., Pernelle C., and Morfin R. 5Alpha-androstane-3beta,7alpha,17beta-triol and 5alpha-androstane-3beta,7beta,17beta-triol as substrates for the human 11beta-hydroxysteroid dehydrogenase type 1. Steroids 72 (2007) 855-864
12. 14C-labelled 5α-androstane-3β,17β-diol. J. Steroid Biochem. 14 (1981) 663-669
13. Seckl J.R., and Walker B.R. 11Beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory. Trends Endocrinol. Metab. 15 (2004) 418-424
14. Wang M. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for the treatment of metabolic syndrome. Curr. Opin. Investig. Drugs 7 (2006) 319-323
15. Wake D.J., and Walker B.R. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity. Endocrine 29 (2006) 101-108
16. Oppermann U. Type 1 11beta-hydroxysteroid dehydrogenase as universal drug target in metabolic diseases?. Endocr. Metab. Immune Disord. Drug Targets 6 (2006) 259-269
17. Miguet L., Zhang Z., Barbier M., and Grigorov M.G. Comparison of a homology model and the crystallographic structure of human 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) in a structure-based identification of inhibitors. J. Comput. Aided Mol. Des. 20 (2006) 67-81
18. Kohn W., and Sham L.J. Self-consistent equations including exchange and correlation effects. Phys. Rev. 140 (1965) A1133-A1138
19. Schweizer R.A., Zurcher M., Balazs Z., Dick B., and Odermatt A. Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human and hamster enzyme. J. Biol. Chem. 279 (2004) 18415-18424
20. Hult M., Elleby B., Shafqat N., Svensson S., Rane A., Jornvall H., Abrahmsen L., and Oppermann U. Human and rodent type 1 11beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism. Cell. Mol. Life Sci. 61 (2004) 992-999
21. Arampatzis S., Kadereit B., Schuster D., Balazs Z., Schweizer R.A., Frey F.J., Langer T., and Odermatt A. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species. J. Mol. Endocrinol. 35 (2005) 89-101
22. Seckl J.R., and Walker B.R. Minireview: 11beta-hydroxysteroid dehydrogenase type 1-a tissue-specific amplifier of glucocorticoid action. Endocrinology 142 (2001) 1371-1376
23. Khalil M.W., Strutt B., Vachon D., and Killinger D.W. Metabolism of dehydroepiandrosterone by cultured human adipose stromal cells: identification of 7alpha-hydroxydehydroepiandrosterone as a major metabolite using high performance liquid chromatography and mass spectrometry. J. Steroid Biochem. Mol. Biol. 46 (1993) 585-595
24. Hennebert O., Pelissier M.A., Le Mée S., Wülfert E., and Morfin R. Anti-inflamatory effects and changes in prostaglandin patterns induced by 7β-hydroxy-epiandrosterone in rats with colitis. J. Steroid Biochem. Mol. Biol. 110 (2008) 255-262
25. Le Mee S., Hennebert O., Ferec C., Wülfert E., and Morfin R. 7β-Hydroxy-epiandrosterone-mediated regulation of the prostaglandin synthesis pathway in human peripheral blood monocytes. Steroids 73 (2008) 1148-1159
26. Haworth O., and Buckley C.D. Resolving the problem of persistence in the switch from acute to chronic inflammation. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 20647-20648
27. Rajakariar R., Hilliard M., Lawrence T., Trivedi S., Colville-Nash P., Bellingan G., Fitzgerald D., Yaqoob M.M., and Gilroy D.W. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 20979-20984
28. Ou Z., Zhao X., Labiche L.A., Strong R., Grotta J.C., Herrmann O., and Aronowski J. Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2-mediated protection of brain after experimental cerebral ischemia in rat. Brain Res. 1096 (2006) 196-203
29. Wayman N.S., Hattori Y., McDonald M.C., Mota-Filipe H., Cuzzocrea S., Pisano B., Chatterjee P.K., and Thiemermann C. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J. 16 (2002) 1027-1040
30. Abdelrahman M., Collin M., and Thiemermann C. The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock. Shock 22 (2004) 555-561